Akebia Therapeutics Inc (AKBA)
Operating Cash Flow Growth
-84.22%
Quarterly · Period ending:
AKBA Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-84.22%period ending
Latest reported-84.22%period ending
AKBA Quarterly Cash from Operations YoY % (-148.81% → -84.22%)
Year-over-year change
High-resolution chart · PNG
AKBA operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -84.2247% | |
| -56.083% | |
| 797.0219% | |
| 519.7909% | |
| 321.9849% | |
| 30.0793% | |
| -93.5009% | |
| 6.5857% | |
| -377.3767% | |
| -10.7994% | |
| 95.779% | |
| -121.201% | |
| 111.8363% | |
| 18.8807% | |
| 12.9426% | |
| 160.0764% | |
| 51.442% | |
| 69.44% | |
| -104.0413% | |
| -106.594% | |
| -269.6427% | |
| 21.0327% | |
| 66.5903% | |
| -347.8569% | |
| 197.013% | |
| 35.047% | |
| -25.0153% | |
| 188.1871% | |
| -526.4784% | |
| -578.4506% | |
| -349.9878% | |
| 77.1848% | |
| -63.0767% | |
| -113.3711% | |
| -117.1193% | |
| -93.3824% | |
| 190.3877% | |
| -154.6518% | |
| 517.5541% | |
| -212.7339% | |
| -122.4561% | |
| 308.8655% | |
| -148.9623% | |
| -61.1834% | |
| -81.6806% | |
| -38.9391% | |
| -87.5228% | |
| -90.7351% | |
| -240.8191% | |
| -292.7662% | |
| -148.8121% |